These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33639946)

  • 1. Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations.
    Tindana P; de Haan F; Amaratunga C; Dhorda M; van der Pluijm RW; Dondorp AM; Cheah PY
    Malar J; 2021 Feb; 20(1):119. PubMed ID: 33639946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019.
    Rathmes G; Rumisha SF; Lucas TCD; Twohig KA; Python A; Nguyen M; Nandi AK; Keddie SH; Collins EL; Rozier JA; Gibson HS; Chestnutt EG; Battle KE; Humphreys GS; Amratia P; Arambepola R; Bertozzi-Villa A; Hancock P; Millar JJ; Symons TL; Bhatt S; Cameron E; Guerin PJ; Gething PW; Weiss DJ
    Malar J; 2020 Oct; 19(1):374. PubMed ID: 33081784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders' perspectives in Burkina Faso and Nigeria.
    Tindana P; Guissou R; Bolarinwa OA; Tou F; de Haan F; Dhorda M; Dondorp AM; Amaratunga C; Mokuolu OA; Ouedraogo JB; Cheah PY
    PLoS One; 2022; 17(9):e0273249. PubMed ID: 36083995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
    van der Pluijm RW; Amaratunga C; Dhorda M; Dondorp AM
    Trends Parasitol; 2021 Jan; 37(1):15-24. PubMed ID: 33060063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
    Sutherland CJ; Babiker H; Mackinnon MJ; Ranford-Cartwright L; El Sayed BB
    Parasitology; 2011 Oct; 138(12):1459-68. PubMed ID: 21810298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion.
    de Haan F; Amaratunga C; Thi VAC; Orng LH; Vonglokham M; Quang TN; Lek D; Boon WPC; Dondorp AM; Moors EHM
    Malar J; 2023 Sep; 22(1):261. PubMed ID: 37674172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.
    Talisuna AO; Karema C; Ogutu B; Juma E; Logedi J; Nyandigisi A; Mulenga M; Mbacham WF; Roper C; Guerin PJ; D'Alessandro U; Snow RW
    Lancet Infect Dis; 2012 Nov; 12(11):888-96. PubMed ID: 23099083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria.
    Bassat Q; Maïga-Ascofaré O; May J; Clain J; Mombo-Ngoma G; Groger M; Adegnika AA; Agobé JD; Djimde A; Mischlinger J; Ramharter M;
    Malar J; 2022 Feb; 21(1):61. PubMed ID: 35193586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic expansion of artemisinin resistance.
    Müller O; Lu GY; von Seidlein L
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis.
    Kunkel A; White M; Piola P
    PLoS Comput Biol; 2021 Mar; 17(3):e1008850. PubMed ID: 33764971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beneficial effect of using ACT for treatment of uncomplicated falciparum malaria on prevention of severe malarial anemia in children].
    Adonis-Koffy L
    Med Trop (Mars); 2008 Oct; 68(5):545-8. PubMed ID: 19068993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.
    Duffey M; Sanchez CP; Lanzer M
    Malar J; 2018 Mar; 17(1):121. PubMed ID: 29558913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.
    Duru V; Witkowski B; Ménard D
    Am J Trop Med Hyg; 2016 Dec; 95(6):1228-1238. PubMed ID: 27928074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
    Woodrow CJ; White NJ
    FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam.
    Cao VAT; Nguyen TQ; Le Quyen D; Boon WPC; Moors EHM; Dondorp AM; de Haan F; Amaratunga C
    Malar J; 2023 Oct; 22(1):326. PubMed ID: 37898749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin resistance or artemisinin-based combination therapy resistance?
    Wongsrichanalai C
    Lancet Infect Dis; 2013 Feb; 13(2):114-5. PubMed ID: 23347632
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
    Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
    Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host immunity to
    Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.